OncBioMune Enters Joint Venture, Preparation for Phase 2 Trial of Novel Cancer …

OncBioMune Enters Joint Venture, Preparation for Phase 2 Trial of Novel Cancer …

During the process of formally creating the JV, OncBioMune and Vitel are working collaboratively to design a Phase 2 clinical trial of ProscaVax, OncBioMune's novel vaccine for the treatment of prostate cancer. The protocol is being developed and the

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Write a comment